Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.600 USD | -3.03% |
|
-4.19% | +30.06% |
| Market Cap | 44.32M 38.32M 35.3M 33.06M 62M 4.21B 62.93M 418M 163M 2.05B 166M 163M 7.1B | P/E Ratio 2024 |
6.84x | P/E Ratio 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 43M 37.17M 34.24M 32.07M 60.15M 4.09B 61.05M 406M 158M 1.99B 161M 158M 6.89B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.03% | ||
| 1 week | -4.19% | ||
| Current month | -5.88% | ||
| 1 month | -20.00% | ||
| 3 months | -8.05% | ||
| 6 months | +14.29% | ||
| Current year | +30.06% |
| 1 week | 1.57 |  | 1.79 |
| 1 month | 1.57 | | 1.86 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.7 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.51 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 63 | 01/12/2020 |
| Director of Finance/CFO | 34 | 21/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 78 | 21/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 01/01/2016 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 22/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/01 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 20/01 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 01/02/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.03% | -4.19% | +128.54% | +39.13% | 44.32M | |
| -3.27% | -1.50% | +29.04% | +328.68% | 30.37B | |
| +0.34% | +0.38% | +1.72% | +18.53% | 21.83B | |
| -0.39% | +4.45% | -24.74% | -42.19% | 7.04B | |
| -2.56% | +4.36% | +0.23% | +74.44% | 4.46B | |
| +0.50% | +4.20% | +7.79% | +63.45% | 2.82B | |
| +18.01% | +17.66% | +32.91% | -21.31% | 1.79B | |
| -1.75% | +14.77% | -9.72% | +787.70% | 1.78B | |
| +7.35% | +5.25% | -14.88% | -65.17% | 1.73B | |
| -0.20% | +2.92% | +17.49% | -2.33% | 1.63B | |
| Average | +1.50% | +5.15% | +16.84% | +118.09% | 7.35B | |
| Weighted average by Cap. | -0.86% | +1.48% | +11.14% | +161.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 40.57M 37.37M 35M 65.64M 4.46B 66.63M 443M 172M 2.17B 176M 172M 7.52B | 38.73M 33.48M 30.84M 28.89M 54.18M 3.68B 54.99M 365M 142M 1.79B 145M 142M 6.2B |
| Net income | 6.7M 5.79M 5.34M 5M 9.38M 637M 9.52M 63.25M 24.61M 310M 25.15M 24.62M 1.07B | 24.58M 21.25M 19.57M 18.33M 34.38M 2.34B 34.89M 232M 90.24M 1.14B 92.23M 90.26M 3.94B |
| Net Debt | 4.4M 3.8M 3.5M 3.28M 6.15M 418M 6.24M 41.47M 16.14M 203M 16.49M 16.14M 704M | -1.32M -1.14M -1.05M -986K -1.85M -126M -1.88M -12.48M -4.85M -61.15M -4.96M -4.86M -212M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 1.600 $ | -3.03% | 4,644 |
| 11/06/26 | 1.650 $ | -6.41% | 2,633 |
| 10/06/26 | 1.763 $ | +1.32% | 7,264 |
| 09/06/26 | 1.740 $ | +3.57% | 6,642 |
| 08/06/26 | 1.680 $ | +0.60% | 1,854 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
